Fulvestrant

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Fulvestrant
Generic name
FULVESTRANT
Manufacturer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Product type
HUMAN PRESCRIPTION DRUG
SPL set ID
46086fe7-190d-4963-97bc-1fe22d36e6d2
SPL ID
6cfbb5fe-940b-4ff1-89a7-e1dfc42b235b
Version
6
Effective date
2025-12-23
Source export date
2026-11-13
Source partition
5
Source file
https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/e10f1fd48195fb7eda0be611a6e3c49a40fe34c69a9c2a8d9e3e3b897ac31621/drug-label-0005-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 16:03:46
Harmonized routes table
Harmonized routes
INTRAMUSCULAR

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings and cautions

5 WARNINGS AND PRECAUTIONS Risk of Bleeding: Use with caution in patients with bleeding diatheses, thrombocytopenia, or anticoagulant use. ( 5.1 ) Increased Exposure in Patients with Hepatic Impairment: Use a 250 mg dose for patients with moderate hepatic impairment. ( 2.2 , 5.2 , 8.6 ) Injection Site Reaction: Use caution while administering fulvestrant injection at the dorsogluteal injection site due to the proximity of the underlying sciatic nerve. ( 5.3 ) Embryo-Fetal Toxicity: Can cause fetal harm. Advise females of reproductive potential of the potential risk to a fetus and to use effective contraception. ( 5.4 , 8.1 , 8.3 ) Immunoassay Measurement of Serum Estradiol: fulvestrant injection can interfere with estradiol measurement by immunoassay, resulting in falsely elevated estradiol levels. ( 5.5 ) 5.1 Risk of Bleeding Because fulvestrant injection is administered intramuscularly, it should be used with caution in patients with bleeding diatheses, thrombocytopenia, or anticoagulant use. 5.2 Increased Exposure in Patients with Hepatic Impairment The safety and pharmacokinetics of fulvestrant injection were evaluated in a study in seven subjects with moderate hepatic impairment (Child-Pugh class B) and seven subjects with normal hepatic function. Exposure was increased in patients with moderate hepatic impairment, therefore, a dose of 250 mg is recommended [see Dosage and Administration ( 2.2 )]. Fulvestrant injection has not been studied in patients with severe hepatic impairment (Child-Pugh class C) [see Use in Specific Populations ( 8.6 )]. 5.3 Injection Site Reaction Injection site related events including sciatica, neuralgia, neuropathic pain, and peripheral neuropathy have been reported with fulvestrant injection. Caution should be taken while administering fulvestrant injection at the dorsogluteal injection site due to the proximity of the underlying sciatic nerve [see Dosage and Administration ( 2.3 ) and Adverse Reactions ( 6.1 )]. 5.4 Embryo-Fetal Toxicity Based on findings from animal studies and its mechanism of action, fulvestrant can cause fetal harm when administered to a pregnant woman. In animal reproduction studies, administration of fulvestrant to pregnant rats and rabbits during organogenesis resulted in embryo-fetal toxicity at daily doses that are significantly less than the maximum recommended human dose. Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during treatment with fulvestrant injection and for one year after the last dose [see Use in Specific Populations ( 8.1 ), ( 8.3 ) and Clinical Pharmacology ( 12.1 )]. 5.5 Immunoassay Measurement of Serum Estradiol Due to structural similarity of fulvestrant and estradiol, fulvestrant can interfere with estradiol measurement by immunoassay, resulting in falsely elevated estradiol levels.

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 3 of 3 · 11 matching rows.

adverse reactions table

<table ID="t8" width="100%"><caption>Table 8: Laboratory Abnormalities &#x2265;10% in Patients Receiving Fulvestrant Plus Abemaciclib and &#x2265;2% Higher Than Fulvestrant Plus Placebo in MONARCH 2 </caption><colgroup><col width="32.533%" align="left"/><col width="12.945%" align="left"/><col width="10.173%" align="left"/><col width="10.159%" align="left"/><col width="12.759%" align="left"/><col width="11.259%" align="left"/><col width="10.173%" align="left"/></colgroup><tbody><tr><td styleCode="Botrule Lrule Rrule Toprule" rowspan="2" align="left" valign="middle"><content styleCode="bold">Laboratory Parameters</content></td><td styleCode="Botrule Rrule Toprule" colspan="3" align="center" valign="top"><content styleCode="bold">Fulvestrant plus Abemaciclib N=441</content></td><td styleCode="Botrule Rrule Toprule" colspan="3" align="center" valign="top"><content styleCode="bold">Fulvestrant plus Placebo N=223</content></td></tr><tr><td styleCode="Botrule Rrule" align="center" valign="top"><content styleCode="bold">All Grades</content> <content styleCode="bold">%</content></td><td styleCode="Botrule Rrule" align="center" valign="top"><content styleCode="bold">Grade 3</content> <content styleCode="bold">%</content></td><td styleCode="Botrule Rrule" align="center" valign="top"><content styleCode="bold">Grade 4</content> <content styleCode="bold">%</content></td><td styleCode="Botrule Rrule" align="center" valign="top"><content styleCode="bold">All Grades</content> <content styleCode="bold">%</content></td><td styleCode="Botrule Rrule" align="center" valign="top"><content styleCode="bold">Grade 3</content> <content styleCode="bold">%</content></td><td styleCode="Botrule Rrule" align="center" valign="top"><content styleCode="bold">Grade 4</content> <content styleCode="bold">%</content></td></tr><tr><td styleCode="Botrule Lrule Rrule" align="left" valign="top">Creatinine increased</td><td styleCode="Botrule Rrule" align="center" valign="top">98</td><td styleCode="Botrule Rrule" align="center" valign="top">1</td><td styleCode="Botrule Rrule" align="center" valign="top">0</td><td styleCode="Botrule Rrule" align="center" valign="top">74</td><td styleCode="Botrule Rrule" align="center" valign="top">0</td><td styleCode="Botrule Rrule" align="center" valign="top">0</td></tr><tr><td styleCode="Botrule Lrule Rrule" align="left" valign="top">White blood cell decreased</td><td styleCode="Botrule Rrule" align="center" valign="top">90</td><td styleCode="Botrule Rrule" align="center" valign="top">23</td><td styleCode="Botrule Rrule" align="center" valign="top">&lt;1</td><td styleCode="Botrule Rrule" align="center" valign="top">33</td><td styleCode="Botrule Rrule" align="center" valign="top">&lt;1</td><td styleCode="Botrule Rrule" align="center" valign="top">0</td></tr><tr><td styleCode="Botrule Lrule Rrule" align="left" valign="top">Neutrophil count decreased</td><td styleCode="Botrule Rrule" align="center" valign="top">87</td><td styleCode="Botrule Rrule" align="center" valign="top">29</td><td styleCode="Botrule Rrule" align="center" valign="top">4</td><td styleCode="Botrule Rrule" align="center" valign="top">30</td><td styleCode="Botrule Rrule" align="center" valign="top">4</td><td styleCode="Botrule Rrule" align="center" valign="top">&lt;1</td></tr><tr><td styleCode="Botrule Lrule Rrule" align="left" valign="top">Anemia</td><td styleCode="Botrule Rrule" align="center" valign="top">84</td><td styleCode="Botrule Rrule" align="center" valign="top">3</td><td styleCode="Botrule Rrule" align="center" valign="top">0</td><td styleCode="Botrule Rrule" align="center" valign="top">33</td><td styleCode="Botrule Rrule" align="center" valign="top">&lt;1</td><td styleCode="Botrule Rrule" align="center" valign="top">0</td></tr><tr><td styleCode="Botrule Lrule Rrule" align="left" valign="top">Lymphocyte count decreased</td><td styleCode="Botrule Rrule" align="center" valign="top">63</td><td styleCode="Botrule Rrule" align="center" valign="top">12</td><td styleCode="Botrule Rrule" align="center" valign="top">&lt;1</td><td styleCode="Botrule Rrule" align="center" valign="top">32</td><td styleCode="Botrule Rrule" align="center" valign="top">2</td><td styleCode="Botrule Rrule" align="center" valign="top">0</td></tr><tr><td styleCode="Botrule Lrule Rrule" align="left" valign="top">Platelet count decreased</td><td styleCode="Botrule Rrule" align="center" valign="top">53</td><td styleCode="Botrule Rrule" align="center" valign="top">&lt;1</td><td styleCode="Botrule Rrule" align="center" valign="top">1</td><td styleCode="Botrule Rrule" align="center" valign="top">15</td><td styleCode="Botrule Rrule" align="center" valign="top">0</td><td styleCode="Botrule Rrule" align="center" valign="top">0</td></tr><tr><td styleCode="Botrule Lrule Rrule" align="left" valign="top">Alanine aminotransferase increased</td><td styleCode="Botrule Rrule" align="center" valign="top">41</td><td styleCode="Botrule Rrule" align="center" valign="top">4</td><td styleCode="Botrule Rrule" align="center" valign="top">&lt;1</td><td styleCode="Botrule Rrule" align="center" valign="top">32</td><td styleCode="Botrule Rrule" align="center" valign="top">1</td><td styleCode="Botrule Rrule" align="center" valign="top">0</td></tr><tr><td styleCode="Botrule Lrule Rrule" align="left" valign="top">Aspartate aminotransferase increased</td><td styleCode="Botrule Rrule" align="center" valign="top">37</td><td styleCode="Botrule Rrule" align="center" valign="top">4</td><td styleCode="Botrule Rrule" align="center" valign="top">0</td><td styleCode="Botrule Rrule" align="center" valign="top">25</td><td styleCode="Botrule Rrule" align="center" valign="top">4</td><td styleCode="Botrule Rrule" align="center" valign="top">&lt;1</td></tr></tbody></table>

adverse reactions table

<table ID="t9" width="100%"><caption>Table 9: Adverse Reactions Occurring in &#x2265;10% and &#x2265;2% Higher Than Fulvestrant Plus Placebo Arm in MONALEESA-3 (All Grades) </caption><col width="27.410%" align="left"/><col width="14.726%" align="left"/><col width="10.784%" align="left"/><col width="10.798%" align="left"/><col width="13.684%" align="left"/><col width="11.784%" align="left"/><col width="10.813%" align="left"/><tfoot><tr><td colspan="7" align="left" valign="top"><paragraph styleCode="footnote">Grading according to CTCAE 4.03. </paragraph></td></tr><tr><td colspan="7" align="left" valign="top"><paragraph styleCode="footnote">CTCAE=Common Terminology Criteria for Adverse Events; N=number of patients </paragraph></td></tr><tr><td colspan="7" align="left" valign="top"><paragraph styleCode="footnote"><sup>1.</sup> Infections; urinary tract infections; respiratory tract infections; gastroenteritis; sepsis (&lt;1%). </paragraph></td></tr></tfoot><tbody><tr><td rowspan="2" align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule"> <content styleCode="bold">Adverse Reactions</content></td><td colspan="3" align="center" valign="top" styleCode="Toprule Botrule Rrule"><content styleCode="bold">Fulvestrant plus Ribociclib</content> <content styleCode="bold">N=483</content></td><td colspan="3" align="center" valign="top" styleCode="Toprule Botrule Rrule"><content styleCode="bold">Fulvestrant plus Placebo</content> <content styleCode="bold">N=241</content></td></tr><tr><td align="center" valign="top" styleCode="Botrule Rrule"><content styleCode="bold">All Grades</content> <content styleCode="bold">%</content></td><td align="center" valign="top" styleCode="Botrule Rrule"><content styleCode="bold">Grade 3</content> <content styleCode="bold">%</content></td><td align="center" valign="top" styleCode="Botrule Rrule"><content styleCode="bold">Grade 4</content> <content styleCode="bold">%</content></td><td align="center" valign="top" styleCode="Botrule Rrule"><content styleCode="bold">All Grades</content> <content styleCode="bold">%</content></td><td align="center" valign="top" styleCode="Botrule Rrule"><content styleCode="bold">Grade 3</content> <content styleCode="bold">%</content></td><td align="center" valign="top" styleCode="Botrule Rrule"><content styleCode="bold">Grade 4</content> <content styleCode="bold">%</content></td></tr><tr><td colspan="7" align="left" valign="top" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Infections and Infestations</content></td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Infections<sup>1</sup></td><td align="center" valign="top" styleCode="Botrule Rrule">42 </td><td align="center" valign="top" styleCode="Botrule Rrule">5 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">30 </td><td align="center" valign="top" styleCode="Botrule Rrule">2 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td colspan="7" align="left" valign="top" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Blood and Lymphatic System Disorders</content></td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Neutropenia </td><td align="center" valign="top" styleCode="Botrule Rrule">69 </td><td align="center" valign="top" styleCode="Botrule Rrule">46 </td><td align="center" valign="top" styleCode="Botrule Rrule">7 </td><td align="center" valign="top" styleCode="Botrule Rrule">2 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Leukopenia </td><td align="center" valign="top" styleCode="Botrule Rrule">27 </td><td align="center" valign="top" styleCode="Botrule Rrule">12 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Anemia </td><td align="center" valign="top" styleCode="Botrule Rrule">17 </td><td align="center" valign="top" styleCode="Botrule Rrule">3 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">5 </td><td align="center" valign="top" styleCode="Botrule Rrule">2 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td colspan="7" align="left" valign="top" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Metabolism and Nutrition Disorders</content></td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Decreased appetite </td><td align="center" valign="top" styleCode="Botrule Rrule">16 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">13 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td colspan="7" align="left" valign="top" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Nervous System Disorders</content></td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Dizziness </td><td align="center" valign="top" styleCode="Botrule Rrule">13 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">8 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td colspan="7" align="left" valign="top" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Respiratory, Thoracic, and Mediastinal Disorders</content></td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Cough </td><td align="center" valign="top" styleCode="Botrule Rrule">22 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">15 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Dyspnea </td><td align="center" valign="top" styleCode="Botrule Rrule">15 </td><td align="center" valign="top" styleCode="Botrule Rrule">1 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">12 </td><td align="center" valign="top" styleCode="Botrule Rrule">2 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td colspan="7" align="left" valign="top" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Gastrointestinal Disorders</content></td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Nausea </td><td align="center" valign="top" styleCode="Botrule Rrule">45 </td><td align="center" valign="top" styleCode="Botrule Rrule">1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">28 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Diarrhea </td><td align="center" valign="top" styleCode="Botrule Rrule">29 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">20 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Vomiting </td><td align="center" valign="top" styleCode="Botrule Rrule">27 </td><td align="center" valign="top" styleCode="Botrule Rrule">1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">13 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Constipation </td><td align="center" valign="top" styleCode="Botrule Rrule">25 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">12 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Abdominal pain </td><td align="center" valign="top" styleCode="Botrule Rrule">17 </td><td align="center" valign="top" styleCode="Botrule Rrule">1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">13 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td colspan="7" align="left" valign="top" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Skin and Subcutaneous Tissue Disorders</content></td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Alopecia </td><td align="center" valign="top" styleCode="Botrule Rrule">19 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">5 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Pruritus </td><td align="center" valign="top" styleCode="Botrule Rrule">20 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">7 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Rash </td><td align="center" valign="top" styleCode="Botrule Rrule">23 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">7 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td colspan="7" align="left" valign="top" styleCode="Botrule Lrule Rrule"><content styleCode="bold">General Disorders and Administration Site Conditions</content></td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Edema peripheral </td><td align="center" valign="top" styleCode="Botrule Rrule">15 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">7 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Pyrexia </td><td align="center" valign="top" styleCode="Botrule Rrule">11 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">7 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td colspan="7" align="left" valign="top" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Investigations</content></td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Alanine aminotransferase increased </td><td align="center" valign="top" styleCode="Botrule Rrule">15 </td><td align="center" valign="top" styleCode="Botrule Rrule">7 </td><td align="center" valign="top" styleCode="Botrule Rrule">2 </td><td align="center" valign="top" styleCode="Botrule Rrule">5 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Aspartate aminotransferase increased </td><td align="center" valign="top" styleCode="Botrule Rrule">13 </td><td align="center" valign="top" styleCode="Botrule Rrule">5 </td><td align="center" valign="top" styleCode="Botrule Rrule">1 </td><td align="center" valign="top" styleCode="Botrule Rrule">5 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr></tbody></table>

adverse reactions table

<table ID="t10" width="100%"><caption>Table 10: Laboratory Abnormalities Occurring in &#x2265;10% of Patients in MONALEESA-3 </caption><col width="29.114%" align="left"/><col width="13.600%" align="left"/><col width="10.700%" align="left"/><col width="11.643%" align="left"/><col width="13.600%" align="left"/><col width="10.657%" align="left"/><col width="10.686%" align="left"/><tbody><tr><td rowspan="2" align="left" valign="middle" styleCode="Toprule Botrule Lrule Rrule"><content styleCode="bold">Laboratory Parameters</content></td><td colspan="3" align="center" valign="top" styleCode="Toprule Botrule Rrule"><content styleCode="bold">Fulvestrant plus Ribociclib</content> <content styleCode="bold">N=483</content></td><td colspan="3" align="center" valign="top" styleCode="Toprule Botrule Rrule"><content styleCode="bold">Fulvestrant plus Placebo</content> <content styleCode="bold">N=241</content></td></tr><tr><td align="center" valign="top" styleCode="Botrule Rrule"><content styleCode="bold">All Grades</content> <content styleCode="bold">%</content></td><td align="center" valign="top" styleCode="Botrule Rrule"><content styleCode="bold">Grade 3</content> <content styleCode="bold">%</content></td><td align="center" valign="top" styleCode="Botrule Rrule"><content styleCode="bold">Grade 4</content> <content styleCode="bold">%</content></td><td align="center" valign="top" styleCode="Botrule Rrule"><content styleCode="bold">All Grades</content> <content styleCode="bold">%</content></td><td align="center" valign="top" styleCode="Botrule Rrule"><content styleCode="bold">Grade 3</content> <content styleCode="bold">%</content></td><td align="center" valign="top" styleCode="Botrule Rrule"><content styleCode="bold">Grade 4</content> <content styleCode="bold">%</content></td></tr><tr><td colspan="7" align="left" valign="top" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Hematology</content></td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Leukocyte count decreased </td><td align="center" valign="top" styleCode="Botrule Rrule">95 </td><td align="center" valign="top" styleCode="Botrule Rrule">25 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">26 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Neutrophil count decreased </td><td align="center" valign="top" styleCode="Botrule Rrule">92 </td><td align="center" valign="top" styleCode="Botrule Rrule">46 </td><td align="center" valign="top" styleCode="Botrule Rrule">7 </td><td align="center" valign="top" styleCode="Botrule Rrule">21 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Hemoglobin decreased </td><td align="center" valign="top" styleCode="Botrule Rrule">60 </td><td align="center" valign="top" styleCode="Botrule Rrule">4 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">35 </td><td align="center" valign="top" styleCode="Botrule Rrule">3 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Lymphocyte count decreased </td><td align="center" valign="top" styleCode="Botrule Rrule">69 </td><td align="center" valign="top" styleCode="Botrule Rrule">14 </td><td align="center" valign="top" styleCode="Botrule Rrule">1 </td><td align="center" valign="top" styleCode="Botrule Rrule">35 </td><td align="center" valign="top" styleCode="Botrule Rrule">4 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Platelet count decreased </td><td align="center" valign="top" styleCode="Botrule Rrule">33 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">1 </td><td align="center" valign="top" styleCode="Botrule Rrule">11 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td colspan="7" align="left" valign="top" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Chemistry</content></td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Creatinine increased </td><td align="center" valign="top" styleCode="Botrule Rrule">65 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">33 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Gamma-glutamyl transferase increased </td><td align="center" valign="top" styleCode="Botrule Rrule">52 </td><td align="center" valign="top" styleCode="Botrule Rrule">6 </td><td align="center" valign="top" styleCode="Botrule Rrule">1 </td><td align="center" valign="top" styleCode="Botrule Rrule">49 </td><td align="center" valign="top" styleCode="Botrule Rrule">8 </td><td align="center" valign="top" styleCode="Botrule Rrule">2 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Aspartate aminotransferase increased </td><td align="center" valign="top" styleCode="Botrule Rrule">49 </td><td align="center" valign="top" styleCode="Botrule Rrule">5 </td><td align="center" valign="top" styleCode="Botrule Rrule">2 </td><td align="center" valign="top" styleCode="Botrule Rrule">43 </td><td align="center" valign="top" styleCode="Botrule Rrule">3 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Alanine aminotransferase increased </td><td align="center" valign="top" styleCode="Botrule Rrule">44 </td><td align="center" valign="top" styleCode="Botrule Rrule">8 </td><td align="center" valign="top" styleCode="Botrule Rrule">3 </td><td align="center" valign="top" styleCode="Botrule Rrule">37 </td><td align="center" valign="top" styleCode="Botrule Rrule">2 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Glucose serum decreased </td><td align="center" valign="top" styleCode="Botrule Rrule">23 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">18 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Phosphorous decreased </td><td align="center" valign="top" styleCode="Botrule Rrule">18 </td><td align="center" valign="top" styleCode="Botrule Rrule">5 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">8 </td><td align="center" valign="top" styleCode="Botrule Rrule">&lt;1 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr><tr><td align="left" valign="top" styleCode="Botrule Lrule Rrule">Albumin decreased </td><td align="center" valign="top" styleCode="Botrule Rrule">12 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">8 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td><td align="center" valign="top" styleCode="Botrule Rrule">0 </td></tr></tbody></table>

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.